AI filing briefs · archive

8-K filings in March 2025, explained

442 material Form 8-K filings that 386 companies we cover made with the SEC in March 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).

Clear

9 of 442 briefs match

newest first · times in ET

GE HealthCare replaces $3.5 billion in credit lines with new JPMorgan-led facilities

Neutral financing Written later 1.011.022.03

On March 27, 2025, GE HealthCare entered into two new unsecured revolving credit facilities with JPMorgan Chase Bank as administrative agent, totaling $3.5 billion in committed amounts. The new facilities replaced two earlier credit agreements, which were terminated without penalty on the same date. The filing describes a refinancing of existing credit capacity rather than new borrowing, and it discloses no drawn amounts.

  • New $3.0 billion senior unsecured revolving credit facility matures March 27, 2030
  • New $0.5 billion 364-day revolving credit facility matures March 26, 2026
  • Replaces a $1.0 billion facility from December 11, 2024 (Citibank) and a $2.5 billion facility from November 4, 2022 (Citibank), both terminated March 27, 2025
Read the filing on SEC.gov ↗
OSKOSHKOSH CORP Mar 31, 4:46 PM ET

Oshkosh enters $500 million PNC term loan maturing March 2027, replacing revolver debt

Neutral financing Written later 1.012.03

On March 31, 2025, Oshkosh entered a Credit Agreement with PNC Bank as administrative agent and borrowed the full $500 million unsecured term loan, using the proceeds to repay certain debt under its existing Bank of America credit agreement. The company says the purpose was to convert certain revolving credit debt into term debt to improve liquidity without increasing debt. The new loan adds a fixed maturity of March 2027 and a leverage covenant that shareholders should track.

  • $500 million unsecured term loan maturing March 2027, prepayable without penalty
  • Interest at Term SOFR plus 0.90% or the Base Rate, at the company's election
  • Maximum leverage ratio of 3.75 to 1.00, temporarily up to 4.25 to 1.00 for certain material acquisitions
  • Existing Credit Agreement with Bank of America remains in effect; covenants are substantially similar
Read the filing on SEC.gov ↗
DRHDiamondRock Hospitality Co Mar 31, 4:18 PM ET

DiamondRock Hospitality amends credit agreement, removing certain mandatory prepayment requirements

Neutral financing Written later 1.01

DiamondRock Hospitality and its subsidiaries signed a Second Amendment to its Sixth Amended and Restated Credit Agreement with Wells Fargo as administrative agent on March 27, 2025. The amendment, among other things, removes certain mandatory prepayment requirements, which gives the company more flexibility over how it repays borrowings under the facility.

  • Amendment dated March 27, 2025, among DiamondRock Hospitality Company, DiamondRock Hospitality Limited Partnership as borrower, certain subsidiaries as guarantors, and Wells Fargo Bank, National Association as administrative agent
  • Amendment removes certain mandatory prepayment requirements
  • Full terms filed as Exhibit 10.1 to the report; the filing does not state dollar amounts
Read the filing on SEC.gov ↗
MEDPMedpace Holdings, Inc. Mar 31, 4:14 PM ET

Medpace extends PNC revolving credit note maturity to March 31, 2026

Neutral financing Written later 1.01

Medpace Holdings and subsidiaries signed Amendment No. 7 to its unsecured credit facility with PNC Bank, National Association, on March 28, 2025. The amendment extends the expiration date of the revolving credit note to March 31, 2026, keeping the company's existing borrowing arrangement in place for another year.

  • Agreement dated March 28, 2025 with PNC Bank, National Association, under the unsecured credit facility
  • Amendment No. 7 extends the revolving credit note expiration date to March 31, 2026
  • Medpace, Inc. is borrower and Medpace IntermediateCo, Inc. is guarantor; full text filed as Exhibit 10.1
Read the filing on SEC.gov ↗
WSWorthington Steel, Inc. Mar 31, 4:10 PM ET

Worthington Steel subsidiary gets CAD $57.5 million BDC loan for Burlington plant

Neutral financing Written later 1.012.03

Tempel Canada Company, a Worthington Steel subsidiary, signed a letter of offer on March 25, 2025 with Business Development Bank of Canada for a loan of up to CAD $57.5 million to build a new manufacturing facility in Burlington, Ontario. Worthington Steel will guarantee part of the loan and provide cost overrun and completion guarantees, which adds financial exposure for the parent company.

  • BDC committed up to CAD $57.5 million, subject to customary closing conditions; the loan matures June 1, 2051
  • Worthington Steel guarantees Tempel Canada's loan obligations, limited to 20% of the loan amount on the date of any demand, with release possible once the balance reaches CAD $40 million
  • Loan is secured by a mortgage on the Burlington property and a lien on certain equipment; draw period lapses March 21, 2026 unless extended
  • Tempel Canada must maintain a Total Debt to Tangible Equity Ratio of 1.0 to 1.0 and a Fixed Charge Coverage Ratio of 1.15 to 1.0, tested annually
Read the filing on SEC.gov ↗
HUMHUMANA INC Mar 31, 4:06 PM ET

Humana prices $250 million add-on to 5.375% senior notes due 2031

Neutral financing Written later 1.012.03

Humana agreed on March 26, 2025 to sell an additional $250 million of its 5.375% Senior Notes due 2031, and completed the offering on March 31, 2025. The add-on brings total outstanding notes in this series to $1.5 billion, and net proceeds of about $247 million are intended for general corporate purposes, which may include repaying existing debt.

  • Additional $250 million of 5.375% Senior Notes due April 15, 2031 sold at 99.941% of principal
  • Total outstanding principal of the series rises to $1.5 billion from $1.25 billion
  • Estimated net proceeds of approximately $247 million for general corporate purposes, which may include debt repayment
Read the filing on SEC.gov ↗
APTVAptiv PLC Mar 31, 4:05 PM ET

Aptiv enters $2 billion amended credit agreement with JPMorgan as administrative agent

Neutral financing Written later 1.012.03

On March 31, 2025, Aptiv and certain subsidiaries entered into an Amended and Restated Credit Agreement with JPMorgan Chase Bank as administrative agent, providing up to $2 billion in a U.S. dollar tranche and a global revolving tranche. The filing says the agreement replaces an earlier credit agreement dated August 17, 2016, as amended in 2021 and 2023, and that the company has no material relationships with the lenders beyond underwriting and share repurchase facilitation. The filing does not state pricing, maturity or amounts drawn, and the financing is a debt facility that shareholders should weigh against its covenants and default terms.

  • Credit Agreement dated March 31, 2025 provides up to $2,000 million in aggregate principal
  • Includes a U.S. Dollar tranche and a global revolving tranche in global currencies
  • Amends and restates the Third Amended and Restated Credit Agreement dated August 17, 2016, as amended in 2021 and April 19, 2023
  • Event of default could make outstanding principal and accrued interest immediately due and payable
Read the filing on SEC.gov ↗
OTTROtter Tail Corp Mar 31, 10:31 AM ET

Otter Tail Power prices $100 million senior unsecured notes in private placement

Neutral financing Written later 1.012.03

Otter Tail Power Company, a subsidiary of Otter Tail Corporation, entered a Note Purchase Agreement on March 27, 2025, issuing $100 million of senior unsecured notes in a private placement. The company plans to use the proceeds for capital expenditures, refinancing existing debt and general corporate purposes, which adds to the subsidiary's debt load and comes with covenants limiting debt to 65% of total capitalization.

  • Series 2025A: $50 million, 5.49% notes due March 27, 2035, issued March 27, 2025
  • Series 2025B: $50 million, 5.98% notes due June 5, 2055, expected to be issued June 5, 2025, subject to closing conditions
  • Covenants cap Interest-bearing Debt at 65% of Total Capitalization and Priority Indebtedness at 20%, tested each fiscal quarter
  • Filing dated March 31, 2025, signed by CFO Todd R. Wahlund
Read the filing on SEC.gov ↗
BXPBXP, Inc. Mar 31, 7:15 AM ET

BXP amends credit facility to $2.95 billion, extends revolver to 2030

Neutral financing Written later 1.012.038.01

BXP's operating partnership amended and restated its credit agreement on March 28, 2025, lifting the revolving commitment from $2.0 billion to $2.250 billion, extending its maturity to March 29, 2030, and adding a $700.0 million term loan that repaid an earlier $700.0 million term loan due May 2025. The changes lengthen the company's borrowing runway and extend the commercial paper backstop, though the filing also records $300.0 million drawn on the revolver after closing.

  • Total borrowing capacity under the 2025 Credit Facility is up to $2.950 billion, with an option to increase to $3.5 billion subject to syndication
  • Revolving Facility commitment rose from $2.0 billion to $2.250 billion and matures March 29, 2030
  • $300.0 million outstanding under the Revolving Facility after closing
  • Commercial paper program limit raised by $250.0 million to $750.0 million
Read the filing on SEC.gov ↗

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.

Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.